Ergoloid induced pleuropulmonary toxicity: Presentation of 3 cases and follow up

M. Mazzei, J. Mazzei (Argentina)

Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Session: Management of sarcoidosis and lung manifestations of systemic diseases
Session type: Thematic Poster Session
Number: 600
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mazzei, J. Mazzei (Argentina). Ergoloid induced pleuropulmonary toxicity: Presentation of 3 cases and follow up. Eur Respir J 2010; 36: Suppl. 54, 600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Typical pulmonary carcinoid tumors: presentation, diagnosis and outcome in 24 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 532s
Year: 2004

30 cases of pulmonary actinomycosis: diagnosis, treatment and outcome
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008

Pulmonary hamartomas mimicking malignancy: 3 case reports
Source: Eur Respir J 2006; 28: Suppl. 50, 90s
Year: 2006

Clinical course in hypersensitivity pneumonitis: a review of 38 cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009

Clinical caracteristics of pulmonary actinomycosis: 10 years‘ follow up
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007


Case 2: Is it pneumonia, pneumonitis, or progressive disease?
Source: International Congress 2017 – CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer?
Year: 2017


Late Breaking Abstract - Phase II trial of pirfenidone in patients with progressive fibrosing unclassifiable ILD (uILD)
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension
Year: 2019




Abscessus pulmonum: Unexpected outcome of surgical treatment; a case presentation
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011


Hepato toxicity during antituberculosis treatment: A statiscal study about 13 cases
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010


Tuberculosis associated with anti-TNFα treatment: series of 9 clinical cases
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007



Case 1: Is it pneumonia, pneumonitis, or progressive disease?
Source: International Congress 2017 – CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer?
Year: 2017


Pulmonary tuberculosis relapses: A report of 44 cases
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011

Pleuropulmonary bastoma in children: an unusual presentation mimicking pneumonia
Source: International Congress 2018 – Paediatric bronchology
Year: 2018


Pneumatocoeles that required surgery in childhood: Report of 2 cases
Source: Annual Congress 2012 - Airway infections in children: from risk factors to treatment
Year: 2012

Fatal acute exacerbation of idiopathic pulmonary fibrosis: report of 4 cases
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007


Case presentation: A fatal endobronchial mucormycosis mimicking as endobronchial tuberculosis
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Idiopathic pulmonary hemosiderosis in children - clinical profile, evolution and response to treatment in eight cases
Source: Eur Respir J 2004; 24: Suppl. 48, 399s
Year: 2004

Case Series: Non-resolving pneumothorax – an early presentation of mesothelioma
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019

Follow up 1 year of amiodarone pulmonary effects
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011


Late Breaking Abstract - Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
Source: Virtual Congress 2020 – ALERT: Infection in adults and children
Year: 2020